Aquestive Therapeutics, Inc. (AQST) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $44.55M | -22.6% |
| 2024 | $57.56M | +13.8% |
| 2023 | $50.58M | +6.1% |
| 2022 | $47.68M | -6.2% |
| 2021 | $50.83M | +10.9% |
| 2020 | $45.85M | -12.8% |
| 2019 | $52.61M | -22.0% |
| 2018 | $67.43M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $44.55M | -22.6% |
| 2024 | $57.56M | +13.8% |
| 2023 | $50.58M | +6.1% |
| 2022 | $47.68M | -6.2% |
| 2021 | $50.83M | +10.9% |
| 2020 | $45.85M | -12.8% |
| 2019 | $52.61M | -22.0% |
| 2018 | $67.43M | — |